Michel, Pierre <br/><br/>
Prognostic value of TP53 transcriptional activity on p21 and bax in patients with esophageal squamous cell carcinomas treated by definitive chemoradiotherapy.  [electronic resource] 

 -  International journal of radiation oncology, biology, physics  Oct 2002 
 - 379-85 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0360-3016 
<br/><br/><label>Standard No.: </label>10.1016/s0360-3016(02)02911-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Carcinoma, Squamous Cell--drug therapy<br/>Cisplatin--administration & dosage<br/>Confidence Intervals<br/>Esophageal Neoplasms--drug therapy<br/>Female<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Male<br/>Middle Aged<br/>Mutation--physiology<br/>Ploidies<br/>Prognosis<br/>Prospective Studies<br/>Proto-Oncogene Proteins--metabolism<br/>Proto-Oncogene Proteins c-bcl-2<br/>Proto-Oncogene Proteins p21(ras)--metabolism<br/>Survival Rate<br/>Transcriptional Activation<br/>Tumor Suppressor Protein p53--genetics<br/>bcl-2-Associated X Protein